Lee J R, Annegers J F, Appel S H
Department of Epidemiology, School of Public Health, University of Texas-Houston Health Science Center, Houston 77225, USA.
J Neurol Sci. 1995 Oct;132(2):207-15. doi: 10.1016/0022-510x(95)00154-t.
We followed two cohorts of Amyotrophic Lateral Sclerosis (ALS) patients to examine the survival and prognostic factors of ALS and the impact of selective referral on prognosis of ALS. The first cohort consisted of population-based incident ALS cases from Harris County, Texas, first diagnosed between 1985 and 1988. The second was a clinical series from a tertiary care center in Houston, Texas, diagnosed between 1977 and 1989. The overall 3-year survival was 29% in the incidence cohort and 32% in the referral cohort; however, the 5-year survival was much lower for the incidence cohort than the referral cohort (4% vs 21%). The large difference in 5-year survival was not explained by the distributions of prognostic factors in the two cohorts but due to stronger unfavorable effects of prognostic factors in the incidence cohort than the referral cohort. In both cohorts, older age at diagnosis, bulbar onset, and positive family history of ALS were unfavorable prognostic factors while blacks had better survival than whites or hispanics. We confirmed that longer duration from onset to diagnosis was a favorable prognostic factor in both cohorts but the effect was more pronounced in the referral series.
我们追踪了两组肌萎缩侧索硬化症(ALS)患者,以研究ALS的生存情况和预后因素,以及选择性转诊对ALS预后的影响。第一组包括得克萨斯州哈里斯县基于人群的新发ALS病例,这些病例于1985年至1988年首次确诊。第二组是得克萨斯州休斯顿一家三级医疗中心的临床系列病例,于1977年至1989年确诊。发病队列的总体3年生存率为29%,转诊队列的为32%;然而,发病队列的5年生存率远低于转诊队列(4%对21%)。5年生存率的巨大差异并非由两组预后因素的分布所解释,而是由于发病队列中预后因素的不利影响比转诊队列更强。在两组中,诊断时年龄较大、延髓起病以及ALS家族史阳性均为不利的预后因素,而黑人的生存率高于白人和西班牙裔。我们证实,从发病到诊断的时间较长在两组中均为有利的预后因素,但在转诊系列中该效应更为明显。